European Association of Dermato-Oncology 16th European Post-Chicago Melanoma Skin Cancer Meeting 2026
€180.00
The post-Chicago melanoma meeting from Hamburg 2026 distils ASCO skin cancer results and new EADO guidance into practical discussion of systemic therapy, biomarkers, rare tumours and immunotherapy side effects.
- 16th edition · 13 programme themes · 6 satellite symposia
- Perioperative & BRAF-targeted melanoma therapy, GEP testing, dermoscopy
- BCC & CSCC guidelines, Merkel cell, uveal melanoma, ICI toxicity
- Instant access · unlimited access in time
Translate the year’s ASCO skin cancer data into European clinical practice
The post-Chicago melanoma meeting held in Hamburg under the Melanoma World Society and EADO reviews ASCO 2026 melanoma and non-melanoma results, the 2026 EADO guidance on basal and squamous cell carcinoma, perioperative and BRAF-targeted therapy, gene expression profiling, Merkel cell carcinoma, uveal melanoma with tebentafusp and brenetafusp, and checkpoint inhibitor toxicity.
-
16thmeeting edition
-
13programme themes
-
6satellite symposia
-
Unlimitedrecording access
The programme
ASCO digest & the new EADO recommendations
Faculty sift the Chicago presentations for melanoma and keratinocyte cancers, highlighting which results matter for daily care. The 2026 EADO guidance for basal cell and cutaneous squamous cell carcinoma follows, along with ongoing trials and likely future strategies.
Systemic melanoma therapy at the post-Chicago melanoma meeting
Neoadjuvant, perioperative and adjuvant immunotherapy are discussed alongside targeted treatment for BRAF-mutated disease. Sequencing choices and biomarker-guided precision oncology frame how therapy may be individualised.
Prognostic testing & early detection
Gene expression profiling sessions compare available assays, set them against Oncotype DX and consider practical implementation. A dermoscopy session revisits early diagnosis across all types of skin cancer.
Merkel cell, uveal melanoma & novel agents
Merkel cell carcinoma is covered from adjuvant and neoadjuvant trials to radiotherapy and advanced disease. ImmTAC agents such as tebentafusp and brenetafusp are examined for metastatic uveal and cutaneous melanoma.
Immunotherapy toxicity & vulnerable patients
Delayed and long-term immune adverse events, rechallenge decisions and immunosuppressive management receive a dedicated block. Talks also address family planning, frail older adults and immunocompromised people with skin cancer.
Lifestyle, radiotherapy & satellite sessions
Exercise, nutrition and the timing of checkpoint inhibitor infusions are linked to outcomes, and evidence for the abscopal effect of radiotherapy is reviewed. Six satellite symposia revisit uveal melanoma, squamous cell carcinoma, early-stage disease and Merkel cell immunotherapy.
Who it’s for
- Dermatologists stay current on melanoma systemic therapy and keratinocyte cancer guidance
- Medical and surgical oncologists review perioperative strategy, sequencing and toxicity management
- Radiation oncologists and dermatopathologists follow multidisciplinary discussion of skin cancer care
- Residents and fellows get a structured overview of the year in dermato-oncology
The consult
Is this a surgical or a medical oncology meeting?
It is mainly medical and multidisciplinary: systemic therapy, guidelines, biomarkers and toxicity. Surgery and radiotherapy appear as part of overall treatment planning.
How many lectures or hours are included?
Neither a lecture count nor a total running time is published. The programme is organised into thirteen themes plus six satellite symposia.
Are sponsored sessions included?
Yes — the six satellite symposia are part of the package and are typically industry-supported, so interpret product-specific claims accordingly.
Does it cover non-melanoma skin cancer?
Yes — basal cell, cutaneous squamous cell and Merkel cell carcinoma all have dedicated sessions alongside the melanoma content.
When will I be able to watch?
The meeting recordings are unlocked for you right after purchase and stay accessible with no expiry date.
Do I get CME credit or a certificate?
No. Derma Academy provides the course files only — no CME or CE credits, MOC points or certificates of completion are included.
The spec label
| Format | Scientific meeting video recording |
|---|---|
| Event | 16th European Post-Chicago Melanoma / Skin Cancer Meeting · Hamburg 2026 |
| Organisers | Melanoma World Society · European Association of Dermato-Oncology |
| Level | Specialist dermato-oncology & multidisciplinary skin cancer care |
| Topics | ASCO 2026 · EADO guidelines · immunotherapy · GEP · uveal melanoma |
| Training models | Lectures · guideline reviews · satellite symposia |
| Discipline | Dermatology · Skin Cancer & Melanoma |
| Delivery | Instant access · unlimited access in time |
Related products
